Lack of suppression of glucagon during OGTT contributes to the reduced incretin effect in type 2 diabetes

被引：0
|
作者：
Knop, F. K.
Vilsboll, T.
Madsbad, S.
Holst, J. J.
Krarup, T.
机构：
[1] Univ Copenhagen, Dept Intenal Med F, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Med Physiol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Endocrinol, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0663
引用
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [1] Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus
    Knop, F. K.
    Vilsboll, T.
    Madsbad, S.
    Holst, J. J.
    Krarup, T.
    [J]. DIABETOLOGIA, 2007, 50 (04) : 797 - 805
  • [2] Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus
    F. K. Knop
    T. Vilsbøll
    S. Madsbad
    J. J. Holst
    T. Krarup
    [J]. Diabetologia, 2007, 50 : 797 - 805
  • [3] Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus
    Shah, P
    Vella, A
    Basu, A
    Basu, R
    Schwenk, WF
    Rizza, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4053 - 4059
  • [4] The initial rise in GIP secretion during OGTT correlates with the initial suppression of glucagon secretion in adolescents with obesity and type 2 diabetes
    Kristinsson, H.
    Manell, H.
    Dahlbom, M.
    Presto, J.
    Garedal, C.
    Ritzen, H.
    Vilhelmsson, M.
    Kilstedt, E.
    Johnson, F.
    Stenberg, H.
    Forslund, A.
    Bergsten, P.
    [J]. DIABETOLOGIA, 2018, 61 : S247 - S247
  • [5] Reduced incretin effect in type 2 diabetes - Cause or consequence of the diabetic state?
    Knop, Filip K.
    Vilsboll, Tina
    Hojberg, Patricia V.
    Larsen, Steen
    Madsbad, Sten
    Volund, Aage
    Holst, Jens J.
    Krarup, Thure
    [J]. DIABETES, 2007, 56 (08) : 1951 - 1959
  • [6] Metabolic Effects on Incretin and Glucagon Secretion in Obesity and Type 2 Diabetes
    Weber, Katharina S.
    Strassburger, Klaus
    Pacini, Giovanni
    Fritsch, Maria
    Bierwagen, Alessandra
    Hwang, Jong Hee
    Szendroedi, Julia
    Muessig, Karsten
    Roden, Michael
    [J]. DIABETES, 2017, 66 : A533 - A533
  • [7] REDUCED INCRETIN EFFECT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES
    NAUCK, M
    STOCKMANN, F
    EBERT, R
    CREUTZFELDT, W
    [J]. DIABETOLOGIA, 1986, 29 (01) : 46 - 52
  • [8] Estimating the incretin effect from a glucose-insulin-glucagon coupled model of OGTT
    Subramanian, V.
    Bagger, J. I.
    Harihar, V.
    Holst, J. J.
    Knop, F. K.
    Vilsboll, T.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S254 - S255
  • [9] Impaired β-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose
    Greenbaum, CJ
    Prigeon, RL
    D'Alessio, DA
    [J]. DIABETES, 2002, 51 (04) : 951 - 957
  • [10] Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
    Manell, Hannes
    Staaf, Johan
    Manukyan, Levon
    Kristinsson, Hjalti
    Cen, Jing
    Stenlid, Rasmus
    Ciba, Iris
    Forslund, Anders
    Bergsten, Peter
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (03): : 1181 - 1189
12345